Globus Medical, Inc. (GMED) |
| 81.49 0.59 (0.73%) 10-28 10:40 |
| Open: | 80.47 |
| High: | 81.6656 |
| Low: | 80.2289 |
| Volume: | 61,047 |
| Market Cap: | 10,941(M) |
| PE Ratio: | 18.35 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 95.79 |
| Resistance 1: | 82.01 |
| Pivot price: | 78.18 |
| Support 1: | 76.16 |
| Support 2: | 72.54 |
| 52w High: | 101.4 |
| 52w Low: | 59.51 |
Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.
| EPS | 3.900 |
| Book Value | 35.520 |
| PEG Ratio | 1.49 |
| Gross Profit | 19.404 |
| Profit Margin (%) | 17.02 |
| Operating Margin (%) | 24.75 |
| Return on Assets (ttm) | 8.7 |
| Return on Equity (ttm) | 11.8 |
Tue, 27 Oct 2026
BlackRock reports a Globus Medical (GMED) stake with sole voting power over 10.3M shares. - Stock Titan
Sun, 25 Oct 2026
Globus Medical (NYSE:GMED) Stock Forecast & Analyst Predictions - Simply Wall Street
Wed, 21 Oct 2026
Globus Medical, Inc. (GMED) Stock Forecasts - Yahoo Finance
Tue, 20 Oct 2026
A Look at Globus Medical Inc (GMED) After 4.4% Gain -- GF Value $97.21 vs Price $78.96 - GuruFocus
Wed, 07 Oct 2026
Reasons to Add Globus Medical Stock to Your Portfolio Now - Yahoo Finance
Wed, 02 Sep 2026
3 Reasons Growth Investors Will Love Globus Medical (GMED) - Yahoo Finance
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |